How did you arrive at that thought?
EMV has had plenty of time to partner or collaborate. The CEO/MD has stepped down so very unlikely there are opportunities in the near term.
Collaboration into new areas of imaging would be something that would be worth pursuing whilst EMV maintain 100% of stroke imaging is where I see the value creation. Licensing is another discussion.
But there isn’t much happening. You can muse about what colour lambo you’ll buy, but it won’t bring 2025/6 any closer.
How did you arrive at that thought? EMV has had plenty of time...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.08 |
Change
-0.080(3.70%) |
Mkt cap ! $177.6M | |||
| Open | High | Low | Value | Volume |
| $2.17 | $2.18 | $2.08 | $134.2K | 63.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $2.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.17 | 685 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| EMV (ASX) Chart |